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ABSTRACT
The impact of clinical liaison on therapy for positive after-hours blood cultures was evaluated. Of 223
positive blood cultures, no change in management occurred in 164 (73%) cases: 115 positive cultures
were regarded as contaminants, and 49 patients were receiving appropriate therapy already. The results
of microscopy or culture altered the antimicrobial management of 59 (27%) patients: therapy was altered
on the basis of microscopy for 33 patients, and was altered for 26 patients when culture results were
available. In total, 94 doses of inappropriate antibiotics were avoided. The main benefit of after-hours
blood cultures was that laboratory results were available a day earlier, facilitating timely initiation of
appropriate therapy and infection control procedures.
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INTRODUCTION
Prompt and appropriate antimicrobial therapy for
bacteraemia reduces mortality [1–4]. In addition,
appropriate antimicrobial prescribing has been
shown to lead to cost savings [5–7] and is thought
to help prevent the spread of antimicrobial resist-
ance [8,9]. Beaumont Hospital (Dublin, Ireland) is
a 650-bed tertiary referral teaching hospital that
contains the national renal transplantation and
neurosurgical units of the Republic of Ireland.
The hospital incorporates an 11-bed general
intensive care unit (ICU) and a ten-bed neurosur-
gical ICU. A hospital-wide antimicrobial policy is
used by admitting doctors to guide initial empir-
ical antimicrobial therapy. Members of the clinical
microbiology team review personally, on a rout-
ine basis, all patients with clinically significant
blood culture isolates. After clinical assessment
on the ward, further investigations and appropri-
ate antimicrobial therapy are advised in consul-
tation with the primary care team responsible for
the patient, and in accordance with the hospital’s
antimicrobial therapy policy. This service oper-
ates from 0900 to 1700 on weekdays, and from
0900 to 1300 at weekends, with a 24-h medical
microbiology on-call telephone service for clinical
advice. It has been shown previously that this
service is both rational and cost-effective, in that it
reduces daily antibiotic costs by 42% [10].
A dedicated biomedical scientist 24-h micro-
biology on-call service was introduced recently in
the hospital. Previously, biomedical scientists
from other disciplines performed out-of-hours
processing of microbiology samples. The new
service incorporates an on-call laboratory service
and an after-hours positive blood culture service.
As a result, microscopy of blood cultures is
available 12 h earlier, culture and antibiotic sus-
ceptibility results are available 24 h earlier, and
laboratory reports are issued 24 h earlier than
previously. The present study describes a pros-
pective analysis of this new service for the first
year of operation in order to determine whether
the availability of positive blood culture results
after-hours resulted in either beneficial changes to
patient management or cost savings.
Corresponding author and reprint requests: F. Fitzpatrick,
Department of Microbiology, Royal College of Surgeons in
Ireland, Education and Research Centre, Smurfit Building,
Beaumont Hospital, Dublin 9, Ireland
E-mail: fidelmafitz@eircom.net
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
MATERIALS AND METHODS
Data were gathered prospectively over a 1-year period from
patients for whom microscopy on blood cultures became
positive out-of-hours. Blood cultures were monitored continu-
ously using a Bactec 9240 system (Beckton Dickinson, Sparks,
MD, USA). ‘After-hours’ was defined as between 1700 and
0900 on weekdays, and after 1300 at weekends and on public
holidays. Emergency and clinically indicated laboratory sam-
ples, excluding blood cultures, were processed on a 24-h basis,
while positive blood cultures were processed (Gram’s stain
and culture set-up) until 2100 each night.
The dedicated microbiology biomedical scientist contacted
the medical microbiologist with the microscopy results for new
positive blood cultures each evening at c. 21.00 hours. The
medical microbiologist then liaised with medical and nursing
staff regarding the relevance of each result, and recommended
any necessary changes in antimicrobial therapy. Demographic
and microbiological data, as well as the dose, frequency and
route of administration of the recommended antimicrobial
agents, were noted. When culture results became available,
patients were reviewed and an assessment was made of the
significance of the result [11]. Details of any recommended
changes in therapy were recorded.
Antibiotic costs were standardised for the study period,
basedon thehospital pharmacycosts ⁄gof antibiotic at the endof
the studyperiod.Anassessmentwas alsomadeof thenumberof
doses of antibiotics that were avoided as a result of the on-call
system. Administrative costs were not taken into consideration.
RESULTS
In total, 223 positive blood culture results were
discussed by telephone after-hours during the
study period. In most cases (164 ⁄ 223; 73%), no
change in management occurred, either because
the blood culture was regarded as a likely
contaminant (115 ⁄ 164) or the patient was already
receiving appropriate therapy (49 ⁄ 164). Most
(105 ⁄ 115) contaminants were coagulase-negative
staphylococci.
The results of microscopy or culture altered the
antimicrobial management of 59 (27%) patients.
While the spectrum of patients (i.e., ICU, oncol-
ogy, renal, medical and surgical patients) was
similar to that of patients for whom there was no
change of therapy, there were less coagulase-
negative staphylococci in this group (Fig. 1).
Positive microscopy resulted in the alteration of
antimicrobial therapy during the same evening
for 33 patients, and for a further 26 patients
during the following day when culture results
became available. The earlier availability of blood
culture results enabled 94 doses of inappropriate
antibiotics to be avoided, representing a saving of
Euro 1101.78. In eight of 20 patients with meth-
icillin-resistant Staphylococcus aureus, and one
patient with vancomycin-resistant enterococci,
this was the first isolate for that patient, which
facilitated earlier treatment, patient isolation and
initiation of appropriate infection control proce-
dures.
Of the 33 patients for whom positive microsco-
py led to immediate alterations in antimicrobial
management, therapy appropriate to the micros-
copy result was commenced in 31 patients. For
the remaining two patients, while the blood
culture was judged to be a contaminant, the
telephone discussion led to the prescription of
more appropriate antimicrobial therapy for the
patient. After clinical liaison the following morn-
ing when culture results were available, antimi-
crobial therapy started the previous evening was
continued in 19 (61%) of 31 patients, while six
patients were changed to more appropriate
agents, and therapy was discontinued in a further
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Fig. 1. Organisms isolated from 223 blood cultures that became positive during the out-of-hours microbiology service: (a)
no change in antimicrobial therapy (n = 164); (b) alteration in antimicrobial therapy (n = 59).
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six patients (two of these patients had no evidence
of sepsis, while four were receiving appropriate
antimicrobial therapy before the blood culture
became positive) (Table 1).
Antimicrobial therapy was altered after clinical
liaison for 26 patients when the culture, but not
the microscopy result, became available. Among
these patients, appropriate antimicrobial therapy
was commenced with ten patients, while therapy
was changed to narrower-spectrum agents for
14 patients previously on appropriate therapy.
For two patients where the blood culture was
regarded as a contaminant, the liaison led to
appropriate changes in antimicrobial therapy.
As this clinical liaison regarding culture results
occurred 24 h earlier than previously, 52 doses
of inappropriate antimicrobial agents were
avoided.
DISCUSSION
Delayed or inappropriate treatment of bacterae-
mia is an important determinant of poor clinical
outcome [1–3,12]. In addition, inappropriate pre-
scribing has been implicated as one of the main
factors in the emergence of antimicrobial resist-
ance [13,14], and has cost implications [15]. In
2002, our hospital spent Euro 2.4 million on
antimicrobial agents, which accounted for 18.9%
of total pharmacy costs. Controlling inappropriate
usage has therefore become a major focus for both
cost-containment and antimicrobial resistance
programmes in the hospital. Antibiotic control
strategies used in our institution include a pro-
active clinical liaison service for the management
of patients with infections, interpretative report-
ing and selective antimicrobial susceptibility
release, restricted formularies, close liaison with
hospital pharmacists via a designated antimicro-
bial pharmacist, and the strong advocacy of
antibiotics with limited antimicrobial spectra.
Few studies have been published on the impact
of an after-hours blood culture service with
clinical liaison on patient management. One study
from the UK analysed 50 positive after-hours
blood cultures over a 4-month period, and con-
cluded that an after-hours service was not justi-
fied because clinical outcome was not influenced
by the earlier intervention [16]. However, another
study, comparing the Vitek AuroMicrobic System
(in which blood culture results are available
within 8 h) with the routine Bactec 460 System
(in which results are available within 48 h),
concluded that the faster method led to cost
savings and more appropriate prescribing of
antimicrobial agents [17]. The present study was
performed prospectively over a 1-year period,
allowing for any seasonal variation in blood
culture numbers. One of the main advantages of
the after-hours service was that microscopy
results were available 12 h earlier, thereby allow-
ing a discussion led by a medical microbiologist
on the appropriateness of any antimicrobial ther-
apy prescribed previously, and an opportunity to
initiate appropriate therapy if necessary. Thus,
33 (14.8%) patients had immediate alterations in
their antimicrobial therapy on the evening that
microscopy results became available, with appro-
priate therapy being commenced that evening for
31 patients. In only six of these patients was this
judged to be unnecessary the following day, when
the results of culture became available. In addi-
tion, earlier culture results allowed inappropriate
antimicrobial agents to be discontinued 24 h
Table 1. Details of alterations in
antimicrobial therapy following 33
after-hours blood culture microsco-
py results
Total CoNS
Staphylococcus
aureus GNB
Streptococci ⁄
enterococci
Total 33 12 4 11 6
Appropriate therapy commenced based on
microscopy
31 11 4 10 6
Continued after culture result 19 6 3 7 3
Changed to more appropriate therapy 6 – 1 2 3
Stopped 6 5 – 1 –
Telephone call led to appropriate therapy
(independent of microscopy)
2 1 – 1 –
Total doses of antimicrobial avoided 42 13 2 21 6
Vancomycin 18 10 2 – 6
Piperacillin–tazobactam 4 – – 4 –
Second ⁄ third-generation cephalosporin 12 – – 12 –
Othera 8 3 – 5 –
aMeropenem, co-amoxiclav, metronidazole.
CoNS, coagulase-negative staphylococci; GNB, Gram-negative bacilli.
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earlier than previously. A further six patients
were changed to narrower-spectrum antimicro-
bial agents the following day. Similarly, of the 26
(11%) patients for whom antimicrobial therapy
was altered after clinical liaison when the culture
results became available, over half (14 patients)
had previous broad-spectrum therapy altered to
more appropriate agents, while antimicrobial
therapy was commenced 24 h earlier than would
have occurred previously for a further ten
patients.
As one of the main factors implicated in the
emergence of antimicrobial resistance is inappro-
priate use of antimicrobial agents [13,14], the
availability of an after-hours service in conjunc-
tion with the daily clinical microbiology service
should also contribute to appropriate antimicro-
bial prescribing and less antibiotic resistance.
Another important benefit of the service was
related to infection control, as it enabled earlier
patient isolation and the initiation of appropriate
infection control procedures when necessary.
Previous criticisms of after-hours blood culture
services have included an increase in staff costs,
extra telephone calls to clinicians (which may not
influence therapy) and a lack of influence on
clinical outcome [16]. In our institution, there
were no significant cost increases associated with
the blood culture service, as the microbiology
biomedical scientist on-call was paid on a ses-
sional basis, irrespective of the workload, and was
based in the laboratory throughout the period,
while the medical microbiologist was on-call as
usual. The service may result in cost savings, as a
recent study has shown that a shorter time to
notification of positive blood cultures is associ-
ated independently with the length of hospitali-
sation after bacteraemia [18]. The present study
did not address the issues of patient outcome,
length of hospitalisation after bacteraemia,
administrative costs, or the impact of the extra
nightly phone calls on the staff on-call and
nursing medical staff on the wards. In a busier
laboratory, or a hospital with a neonatal ICU,
the potential extra workload on the on-call bio-
medical scientist might require alterations to the
system described above.
In conclusion, there appeared to be benefits
from an after-hours blood culture service that
permitted the availability of microscopy results
12 h earlier, the availability of culture results 24 h
earlier, and the issue of laboratory reports 24 h
earlier. After-hours discussions on antimicrobial
treatment resulted in inappropriate agents being
discontinued and treatment with more appropri-
ate agents being started earlier. As patients were
reviewed by the microbiology team 1 day earlier,
there were some immediate cost savings, possibly
combined with important infection control and
antimicrobial resistance implications in the longer
term.
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